InSightec to bring Exablate to Australia, Taiwan

Israeli focused-ultrasound developer InSightec has received regulatory approval from the Australian and Taiwanese governments for the commercial distribution of its ExAblate 2000 MR-guided focused ultrasound (MRgFUS) system.

The incisionless surgery system is used for the treatment of uterine fibroids, according to the Haifa-based vendor.

By staff writers
June 21, 2006

Related Reading

InSightec reports first North American MRgFUS patient, May 31, 2006

Image guidance evolves into imaging therapy, May 12, 2006

Rapid interleaved technique speeds MRgFUS fibroid treatment, May 2, 2006

InSightec completes ExAblate African-American enrollment, March 21, 2006

Copyright © 2006

Page 1 of 57
Next Page